CoChat

Primary cilia promote the differentiation of human neurons through the WNT signaling pathway

Open access

Published version of a preprint

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Abstract

Background: Primary cilia emanate from most human cell types, including neurons. Cilia are important for communicating with the cell’s immediate environment: signal reception and transduction to/from the ciliated cell. Deregulation of ciliary signaling can lead to ciliopathies and certain neurodevelopmental disorders. In the developing brain cilia play well-documented roles for the expansion of the neural progenitor cell pool, while information about the roles of cilia during post-mitotic neuron differentiation and maturation is scarce. Results: We employed ciliated Lund Human Mesencephalic (LUHMES) cells in time course experiments to assess the impact of ciliary signaling on neuron differentiation. By comparing ciliated and non-ciliated neuronal precursor cells and neurons in wild type and in RFX2 -/- mutant neurons with altered cilia, we discovered an early-differentiation “ciliary time window” during which transient cilia promote axon outgrowth, branching and arborization. Experiments in neurons with IFT88 and IFT172 ciliary gene knockdowns, leading to shorter cilia, confirm these results. Cilia promote neuron differentiation by tipping WNT signaling toward the non-canonical pathway, in turn activating WNT pathway output genes implicated in cyto-architectural changes. Conclusions: We provide a mechanistic entry point into when and how ciliary signaling coordinates, promotes and translates into anatomical changes. We hypothesize that ciliary alterations causing neuron differentiation defects may result in “mild” impairments of brain development, possibly underpinning certain aspects of neurodevelopmental disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12915-024-01845-w

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Stages of neuron differentiation: cilia promote axon outgrowth. A Schematic illustration of neuron differentiation stages [36]: stage 1 – growth cone protrusions during neuron polarization; stage 2a – symmetric bipolar stage with microtubule invasion into growth cones, first neurite extension; stage 2b – symmetric bipolar stage with microtubule bundles consolidation, further neurite extension; stage 3 – the emerging axon outgrows the opposite neurite breaking the bipolar symmetry; stages 4 and 5 – dendrites and dendritic spines formation, further maturation with formation of synapses. B-F Staging of human LUHMES neuron differentiation: immunocytochemistry detects nuclei (Hoechst staining), the cytoskeleton (Phalloidin stains F-actin), microtubule bundles (TUBB3) and emerging synapses (PSD95). G Neurons at differentiation stage 2a display a significantly larger diameter of the emerging axon than neurons at stages 2b and 3 (n = 20–26). H Axon elongation between differentiation stages 2a, 2b and 3 (n = 21–37). I Phalloidin staining is used to identify the cell body (dashed line) and the axon marker TRIM46 to recognize the initial segment of the axon (arrowhead and bracket), the diameter of which was used for measurements. Mean values are shown ± s.e.m. (G) and displayed as Box and Whisker plots (min to max) (H). The results are from two independent experiments including two technical replicates each. We conducted regular one-way ANOVA analyses with multiple comparisons (Bonferroni’s test) between groups. **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 1 Stages of neuron differentiation: cilia promote axon outgrowth. A Schematic illustration of neuron differentiation stages [36]: stage 1 – growth cone protrusions during neuron polarization; stage 2a – symmetric bipolar stage with microtubule invasion into growth cones, first neurite extension; stage 2b – symmetric bipolar stage with microtubule bundles consolidation, further neurite extension; stage 3 – the emerging axon outgrows the opposite neurite breaking the bipolar symmetry; stages 4 and 5 – dendrites and dendritic spines formation, further maturation with formation of synapses. B-F Staging of human LUHMES neuron differentiation: immunocytochemistry detects nuclei (Hoechst staining), the cytoskeleton (Phalloidin stains F-actin), microtubule bundles (TUBB3) and emerging synapses (PSD95). G Neurons at differentiation stage 2a display a significantly larger diameter of the emerging axon than neurons at stages 2b and 3 (n = 20–26). H Axon elongation between differentiation stages 2a, 2b and 3 (n = 21–37). I Phalloidin staining is used to identify the cell body (dashed line) and the axon marker TRIM46 to recognize the initial segment of the axon (arrowhead and bracket), the diameter of which was used for measurements. Mean values are shown ± s.e.m. (G) and displayed as Box and Whisker plots (min to max) (H). The results are from two independent experiments including two technical replicates each. We conducted regular one-way ANOVA analyses with multiple comparisons (Bonferroni’s test) between groups. **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 2 Differentiation advantage of ciliated neurons as compared to non-ciliated neurons in a LUHMES WT background. A The percentage of ciliation in differentiating human LUHMES neurons increases once neurons exit the cell cycle (d1), peaks in differentiating neurons (d3) and then decreases during the later stages of neuron differentiation and maturation (d4-d6). The percentage of neurons reaching stage 3 of differentiation steadily increases throughout the entire differentiation and maturation process (n = 134–394). B-E Populations of ciliated LUHMES neurons (n = 39–128) are more efficient than non-ciliated LUHMES neurons (n = 15–116) in breaking the bipolar symmetry of stages 2a and 2b, and thus, in promoting axon outgrowth (d1-d3 summarized and individual days). F Identification by immunocytochemistry of nuclei (Hoechst staining), centrosomes/basal bodies (PCNT marker), cilia (ARL13B marker) and axons (TAU marker) reveals that the majority of stage 3 differentiating neurons in a given population are ciliated. Arrowheads point to stage 3 neurons either being ciliated (in green) or non-ciliated (in red). Mean values ± s.e.m. are shown. The results are from a minimum of three independent experiments with a total of at least six technical replicates. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 2 Differentiation advantage of ciliated neurons as compared to non-ciliated neurons in a LUHMES WT background. A The percentage of ciliation in differentiating human LUHMES neurons increases once neurons exit the cell cycle (d1), peaks in differentiating neurons (d3) and then decreases during the later stages of neuron differentiation and maturation (d4-d6). The percentage of neurons reaching stage 3 of differentiation steadily increases throughout the entire differentiation and maturation process (n = 134–394). B-E Populations of ciliated LUHMES neurons (n = 39–128) are more efficient than non-ciliated LUHMES neurons (n = 15–116) in breaking the bipolar symmetry of stages 2a and 2b, and thus, in promoting axon outgrowth (d1-d3 summarized and individual days). F Identification by immunocytochemistry of nuclei (Hoechst staining), centrosomes/basal bodies (PCNT marker), cilia (ARL13B marker) and axons (TAU marker) reveals that the majority of stage 3 differentiating neurons in a given population are ciliated. Arrowheads point to stage 3 neurons either being ciliated (in green) or non-ciliated (in red). Mean values ± s.e.m. are shown. The results are from a minimum of three independent experiments with a total of at least six technical replicates. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 3 Cilia structure and function are altered in human LUHMES RFX2 -/- mutants. See also Additional file 2: Fig. S1. A Schematic illustration of the RFX2 transcription factor (TF) gene structure with functional protein domains indicated: AD – activation domain, DBD – DNA binding domain, B and C – domains B and C of unknown function, DIM – dimerization domain. CRISPR/Cas9-engineered, small deletions lead to reading frame shifts upstream of the RFX2 DBD, essential for TF functionality, thereby creating an RFX2 -/- knockout mutant. B Western blot analyses of RFX2 protein expression in LUHMES wild-type (WT) and RFX2 -/- mutants: In the RFX2 -/- mutant RFX2 protein expression is completely absent during early neuron differentiation time points (d1-d3) and at the end of differentiation and maturation (d6). Also, no protein expression of a hypothetical, predicted truncated RFX2 protein product was detectable because of CRISPR/Cas9 mutagenesis. The housekeeping protein GAPDH was used as a loading control. C WT (n = 171) and RFX2 -/- (n = 215) neuronal populations display a similar and uniform distribution of cilia orientation in 3D space. D Cilia of RFX2 -/- mutants are longer than WT cilia in differentiating neurons (d3). Immunofluorescence-based length measurements: ARL13B marks the ciliary shaft, PCNT marks the basal body. Statistics: WT (n = 76), RFX2 -/- (n = 111). E Representative immunocytochemistry images of WT vs elongated RFX2 -/- cilia. F Ciliary signaling pathway genes relevant for neuron differentiation are deregulated between differentiating WT and RFX2 -/- neurons. Mean values ± s.e.m. are shown from two independent experiments with a minimum of three technical replicates each. We conducted regular one-way ANOVA (D) and two-way ANOVA analyses (C, F) (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 3 Cilia structure and function are altered in human LUHMES RFX2 -/- mutants. See also Additional file 2: Fig. S1. A Schematic illustration of the RFX2 transcription factor (TF) gene structure with functional protein domains indicated: AD – activation domain, DBD – DNA binding domain, B and C – domains B and C of unknown function, DIM – dimerization domain. CRISPR/Cas9-engineered, small deletions lead to reading frame shifts upstream of the RFX2 DBD, essential for TF functionality, thereby creating an RFX2 -/- knockout mutant. B Western blot analyses of RFX2 protein expression in LUHMES wild-type (WT) and RFX2 -/- mutants: In the RFX2 -/- mutant RFX2 protein expression is completely absent during early neuron differentiation time points (d1-d3) and at the end of differentiation and maturation (d6). Also, no protein expression of a hypothetical, predicted truncated RFX2 protein product was detectable because of CRISPR/Cas9 mutagenesis. The housekeeping protein GAPDH was used as a loading control. C WT (n = 171) and RFX2 -/- (n = 215) neuronal populations display a similar and uniform distribution of cilia orientation in 3D space. D Cilia of RFX2 -/- mutants are longer than WT cilia in differentiating neurons (d3). Immunofluorescence-based length measurements: ARL13B marks the ciliary shaft, PCNT marks the basal body. Statistics: WT (n = 76), RFX2 -/- (n = 111). E Representative immunocytochemistry images of WT vs elongated RFX2 -/- cilia. F Ciliary signaling pathway genes relevant for neuron differentiation are deregulated between differentiating WT and RFX2 -/- neurons. Mean values ± s.e.m. are shown from two independent experiments with a minimum of three technical replicates each. We conducted regular one-way ANOVA (D) and two-way ANOVA analyses (C, F) (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 4 Altered cilia affect different aspects of human LUHMES neuron differentiation: axon outgrowth and branching pattern. A The percentage of ciliation in differentiating human LUHMES neurons increases and declines slightly earlier in RFX2 -/- mutants as compared to WT neurons. The percentage of neurons reaching stage 3 of differentiation is delayed in RFX2 -/- mutants as compared to WT neurons throughout the entire differentiation and maturation process (WT n = 134–394; RFX2 -/- n = 162–492). B Altered cilia of LUHMES RFX2 -/- neurons do not render axon outgrowth more efficient (n = 29–90), as compared to non-ciliated LUHMES RFX2 -/- neurons (n = 24–122) (d1-d3 summarized and individual days). C-D Axons of ciliated neurons (n = 69–80) are more branched and arborized as compared to non-ciliated neurons n = 48–107 in WT, whereas in RFX2 -/- mutants there is no difference between ciliated (n = 43–84) and non-ciliated neurons n = 34–103). E Detection by immunocytochemistry demonstrates the effect the cilium imparts on the complexity of axon branching in WT neurons: top – ciliated neuron, bottom – non-ciliated neuron (circles indicate centrosome with or without a cilium; arrowheads indicate axon branch points); Hoechst stain – nucleus, PCNT – centrosome/basal body marker, ARL13B – ciliary marker, Phalloidin – cytoskeleton/F-actin marker. Mean values are shown ± s.d. (A, C-D) and ± s.e.m. (B). The results are from a minimum of three independent experiments with a minimum of two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 4 Altered cilia affect different aspects of human LUHMES neuron differentiation: axon outgrowth and branching pattern. A The percentage of ciliation in differentiating human LUHMES neurons increases and declines slightly earlier in RFX2 -/- mutants as compared to WT neurons. The percentage of neurons reaching stage 3 of differentiation is delayed in RFX2 -/- mutants as compared to WT neurons throughout the entire differentiation and maturation process (WT n = 134–394; RFX2 -/- n = 162–492). B Altered cilia of LUHMES RFX2 -/- neurons do not render axon outgrowth more efficient (n = 29–90), as compared to non-ciliated LUHMES RFX2 -/- neurons (n = 24–122) (d1-d3 summarized and individual days). C-D Axons of ciliated neurons (n = 69–80) are more branched and arborized as compared to non-ciliated neurons n = 48–107 in WT, whereas in RFX2 -/- mutants there is no difference between ciliated (n = 43–84) and non-ciliated neurons n = 34–103). E Detection by immunocytochemistry demonstrates the effect the cilium imparts on the complexity of axon branching in WT neurons: top – ciliated neuron, bottom – non-ciliated neuron (circles indicate centrosome with or without a cilium; arrowheads indicate axon branch points); Hoechst stain – nucleus, PCNT – centrosome/basal body marker, ARL13B – ciliary marker, Phalloidin – cytoskeleton/F-actin marker. Mean values are shown ± s.d. (A, C-D) and ± s.e.m. (B). The results are from a minimum of three independent experiments with a minimum of two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 5 siRNA knockdown of essential ciliary genes IFT88 and IFT172 leads to axon outgrowth and branching defects. A Gene-specific siRNA significantly downregulates the expression of IFT88 and IFT172 as compared to control samples treated with non-specific scrambled siRNA or when untreated. B Knockdown (KD) of IFT88 and IFT172 expression results in fewer ciliated LUHMES neurons than in the control (scrambled siRNA n = 271; siRNA IFT88 n = 314; siRNA IFT172 n = 405). C Differently from the WT vs RFX2 -/- backgrounds (cf. Fig. 3C), a significantly higher percentage of cilia in IFT88 KD (n = 66) and IFT172 KD (n = 72) appears to be vertically oriented as compared to the control (n = 260), strongly suggesting an increased total amount of severely truncated/shorter cilia in horizontal or tilted orientation indistinguishable from the vertical orientation. D Cilia length is quantified by the PyT method and confirms that cilia of IFT88 KD (n = 66) and IFT172 KD (n = 72) neurons are shorter than the control ones (n = 260). E–G Immunocytochemistry detection of nuclei (Hoechst staining), centrosomes/basal bodies (PCNT marker) and cilia (ARL13B marker) displays the distribution of vertical (and truncated) cilia in IFT88 KD and IFT172 KD neurons. Arrowheads exemplify centrosomes of non-ciliated neurons. H Reduced expression of IFT88 and IFT172 leads to axon outgrowth defects of ciliated LUHMES neurons (scrambled siRNA n = 217; siRNA IFT88 n = 148; siRNA IFT172 n = 218), similar to non-ciliated neurons (scrambled siRNA n = 54; siRNA IFT88 n = 166; siRNA IFT172 n = 187). I Axons of IFT88 KD (n = 29) and IFT172 KD (n = 43) ciliated neurons are significantly less branched than the axons of control neurons (n = 55), similar to the axons of non-ciliated neurons (scrambled siRNA n = 22; siRNA IFT88 n = 30; siRNA IFT172 n = 33). L-N Representative images of immunocytochemistry of axon branching defects in IFT88 KD and IFT172 KD ciliated neurons (circles localize primary cilia; arrowheads point to axon branches); Hoechst staining – nucleus, ARL13B – ciliary marker, Phalloidin – cytoskeleton/F-actin marker. Mean values are shown ± s.d. (I) and ± s.e.m. (A-D, H). The results are from two independent experiments with a minimum of three technical replicates each. We conducted regular one-way ANOVA (A-B, D) and two-way ANOVA analyses (C, H-I) (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 5 siRNA knockdown of essential ciliary genes IFT88 and IFT172 leads to axon outgrowth and branching defects. A Gene-specific siRNA significantly downregulates the expression of IFT88 and IFT172 as compared to control samples treated with non-specific scrambled siRNA or when untreated. B Knockdown (KD) of IFT88 and IFT172 expression results in fewer ciliated LUHMES neurons than in the control (scrambled siRNA n = 271; siRNA IFT88 n = 314; siRNA IFT172 n = 405). C Differently from the WT vs RFX2 -/- backgrounds (cf. Fig. 3C), a significantly higher percentage of cilia in IFT88 KD (n = 66) and IFT172 KD (n = 72) appears to be vertically oriented as compared to the control (n = 260), strongly suggesting an increased total amount of severely truncated/shorter cilia in horizontal or tilted orientation indistinguishable from the vertical orientation. D Cilia length is quantified by the PyT method and confirms that cilia of IFT88 KD (n = 66) and IFT172 KD (n = 72) neurons are shorter than the control ones (n = 260). E–G Immunocytochemistry detection of nuclei (Hoechst staining), centrosomes/basal bodies (PCNT marker) and cilia (ARL13B marker) displays the distribution of vertical (and truncated) cilia in IFT88 KD and IFT172 KD neurons. Arrowheads exemplify centrosomes of non-ciliated neurons. H Reduced expression of IFT88 and IFT172 leads to axon outgrowth defects of ciliated LUHMES neurons (scrambled siRNA n = 217; siRNA IFT88 n = 148; siRNA IFT172 n = 218), similar to non-ciliated neurons (scrambled siRNA n = 54; siRNA IFT88 n = 166; siRNA IFT172 n = 187). I Axons of IFT88 KD (n = 29) and IFT172 KD (n = 43) ciliated neurons are significantly less branched than the axons of control neurons (n = 55), similar to the axons of non-ciliated neurons (scrambled siRNA n = 22; siRNA IFT88 n = 30; siRNA IFT172 n = 33). L-N Representative images of immunocytochemistry of axon branching defects in IFT88 KD and IFT172 KD ciliated neurons (circles localize primary cilia; arrowheads point to axon branches); Hoechst staining – nucleus, ARL13B – ciliary marker, Phalloidin – cytoskeleton/F-actin marker. Mean values are shown ± s.d. (I) and ± s.e.m. (A-D, H). The results are from two independent experiments with a minimum of three technical replicates each. We conducted regular one-way ANOVA (A-B, D) and two-way ANOVA analyses (C, H-I) (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 6 Transcriptomics confirm the delay in differentiation of human RFX2 -/- LUHMES neurons. See also Additional file 2: Fig. S3-S5. A Principal component analysis of 78 (41 WT and 37 RFX2 -/-) LUHMES STRT RNA-seq time course samples, representing the process of neuron differentiation from d0 to d6. Numbers represent the days and arrows connect the neighboring days. B Similarity heat map of SingleR annotation scores of different types of human fetal midbrain cells and neurons [48] using the 78 LUHMES WT and RFX2 -/- samples as reference. Note the apparent differentiation delay of RFX2 -/-, visible in the comparisons to differentiating neuronal cell types (d1/d2-d6,upper right corner), while in the comparisons to precursor cell types (d0; middle left) no differences between WT and RFX2 -/- are apparent. C Left: Scaled expression profile of 1,574 genes downregulated in RFX2 -/- LUHMES STRT RNA-seq samples (Cluster 3) throughout the differentiation time course. 3,476 genes with a significantly variable expression between WT and RFX2 -/- throughout the time course were clustered into three clusters based on their expression patterns during the differentiation process. Lines are local polynomial regression fittings of the scaled expression of the genes in each cluster, depicted in blue (WT) and in red (RFX2 -/-). Right: Gene ontology (GO) enrichment analysis of these 1,574 genes in Cluster 3. The red dashed line represents the adjusted p-value = 0.05. Clusters 1–3 are depicted side-by-side in Additional file 2: Fig. S3. D Transcription factor binding motif enrichment analysis of significantly downregulated transcript far 5’ ends (TFEs) in RFX2 -/- LUHMES STRT RNA-seq samples at day 2 and day 3: only the top five significantly enriched motifs are listed. The complete transcription factor binding motif enrichment analysis throughout the time course of neuron differentiation and maturation (d0-d6) is shown in Additional file 2: Fig. S5
Fig. 6 Transcriptomics confirm the delay in differentiation of human RFX2 -/- LUHMES neurons. See also Additional file 2: Fig. S3-S5. A Principal component analysis of 78 (41 WT and 37 RFX2 -/-) LUHMES STRT RNA-seq time course samples, representing the process of neuron differentiation from d0 to d6. Numbers represent the days and arrows connect the neighboring days. B Similarity heat map of SingleR annotation scores of different types of human fetal midbrain cells and neurons [48] using the 78 LUHMES WT and RFX2 -/- samples as reference. Note the apparent differentiation delay of RFX2 -/-, visible in the comparisons to differentiating neuronal cell types (d1/d2-d6,upper right corner), while in the comparisons to precursor cell types (d0; middle left) no differences between WT and RFX2 -/- are apparent. C Left: Scaled expression profile of 1,574 genes downregulated in RFX2 -/- LUHMES STRT RNA-seq samples (Cluster 3) throughout the differentiation time course. 3,476 genes with a significantly variable expression between WT and RFX2 -/- throughout the time course were clustered into three clusters based on their expression patterns during the differentiation process. Lines are local polynomial regression fittings of the scaled expression of the genes in each cluster, depicted in blue (WT) and in red (RFX2 -/-). Right: Gene ontology (GO) enrichment analysis of these 1,574 genes in Cluster 3. The red dashed line represents the adjusted p-value = 0.05. Clusters 1–3 are depicted side-by-side in Additional file 2: Fig. S3. D Transcription factor binding motif enrichment analysis of significantly downregulated transcript far 5’ ends (TFEs) in RFX2 -/- LUHMES STRT RNA-seq samples at day 2 and day 3: only the top five significantly enriched motifs are listed. The complete transcription factor binding motif enrichment analysis throughout the time course of neuron differentiation and maturation (d0-d6) is shown in Additional file 2: Fig. S5CC BY · PubMed Central
Fig. 7 WNT signaling is essential for promoting human LUHMES neuron differentiation. A-B Inhibiting WNT signaling by treating LUHMES neurons with the antagonist Wnt-C59 negatively affects axon outgrowth (how efficiently neurons reach differentiation stage 3) in (A) WT (vehicle n = 190; Wnt-C59 n = 301) but not in (B) an RFX2 -/- background (vehicle n = 214; Wnt-C59 n = 242). Control (vehicle): the same treatment, but without antagonist. C-D WT ciliated neurons (n = 99) reach differentiation stage 3 more efficiently than non-ciliated neurons (n = 91) in the control experiment (vehicle), while no difference was observed between ciliated (n = 129) and non-ciliated neurons (n = 172) after treatment with the antagonist Wnt-C59 (C). No differences were observed in RFX2 -/- neurons (D) under the same experimental conditions (ciliated (n = 114) versus non-ciliated (n = 100); with (n = 129) versus without (n = 113) antagonist Wnt-C59). E–F Wnt-C59 treatment deregulates axon branching. In the control experiment (vehicle), axon branching is promoted in WT ciliated neurons (n = 37) as compared to non-ciliated neurons (n = 38). Upon treatment with the antagonist Wnt-C59 this difference is alleviated (ciliated n = 34; non-ciliated n = 50) (E). In RFX2 -/- neurons with altered cilia there are no differences in axon branching between ciliated (n = 43) and non-ciliated neurons (n = 22) in the control experiment (vehicle); likewise, for the treatment with the antagonist Wnt-C59 (ciliated n = 38; non-ciliated n = 43) (F). Mean values are shown ± s.e.m. (A-D) and ± s.d. (E–F). The results are from two independent experiments with a minimum of three technical replicates each. We conducted an unpaired two-sided t-test (95% confidence level) (A-B), and regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between conditions (C-F). *p < 0.05; ***p < 0.0005
Fig. 7 WNT signaling is essential for promoting human LUHMES neuron differentiation. A-B Inhibiting WNT signaling by treating LUHMES neurons with the antagonist Wnt-C59 negatively affects axon outgrowth (how efficiently neurons reach differentiation stage 3) in (A) WT (vehicle n = 190; Wnt-C59 n = 301) but not in (B) an RFX2 -/- background (vehicle n = 214; Wnt-C59 n = 242). Control (vehicle): the same treatment, but without antagonist. C-D WT ciliated neurons (n = 99) reach differentiation stage 3 more efficiently than non-ciliated neurons (n = 91) in the control experiment (vehicle), while no difference was observed between ciliated (n = 129) and non-ciliated neurons (n = 172) after treatment with the antagonist Wnt-C59 (C). No differences were observed in RFX2 -/- neurons (D) under the same experimental conditions (ciliated (n = 114) versus non-ciliated (n = 100); with (n = 129) versus without (n = 113) antagonist Wnt-C59). E–F Wnt-C59 treatment deregulates axon branching. In the control experiment (vehicle), axon branching is promoted in WT ciliated neurons (n = 37) as compared to non-ciliated neurons (n = 38). Upon treatment with the antagonist Wnt-C59 this difference is alleviated (ciliated n = 34; non-ciliated n = 50) (E). In RFX2 -/- neurons with altered cilia there are no differences in axon branching between ciliated (n = 43) and non-ciliated neurons (n = 22) in the control experiment (vehicle); likewise, for the treatment with the antagonist Wnt-C59 (ciliated n = 38; non-ciliated n = 43) (F). Mean values are shown ± s.e.m. (A-D) and ± s.d. (E–F). The results are from two independent experiments with a minimum of three technical replicates each. We conducted an unpaired two-sided t-test (95% confidence level) (A-B), and regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between conditions (C-F). *p < 0.05; ***p < 0.0005CC BY · PubMed Central
Fig. 8 The intracellular localization of β-catenin, the major WNT signaling pathway mediator, is regulated by primary cilia. A-B The active (non-phosphorylated) form of β-catenin is significantly upregulated in an RFX2 -/- background as compared to WT neurons. This upregulation is particularly strong on d2 and d3 of neuron differentiation, the two time points with the highest percentage of ciliation (cf. Fig. 2A). Quantification of expression values (A) was carried out from western blot analysis (B) relative to the housekeeping protein GAPDH (loading control). C-D Active β-catenin immunocytochemistry staining of WT and RFX2 -/- neurons highlights differences between genotypes in intracellular protein localization: note the more prominent nuclear localization in the RFX2 -/- background and in non-ciliated WT neurons as compared to ciliated WT neurons. Circles define nuclei and dashed lines define the cell body; the ciliary marker is ARL13B (green). E–F Quantification of active β-catenin localization based on the ratio of immunofluorescence intensity between the cytoplasm and the nucleus on d1, d2 and d3 of LUHMES neuron differentiation. In WT, ciliated neurons (n = 39–167) more strongly promote β-catenin degradation in the cytoplasm, resulting in diminished translocation to the nucleus of the active form (lower ratio), as compared to non-ciliated neurons (n = 44–95) (higher ratio) (E). In an RFX2 -/- background, ciliated (n = 16–77) and non-ciliated neurons (n = 28–57) show no differences in regulating β-catenin intracellular localization (equal ratios) (F). Mean values are shown ± s.e.m. (normalized to GAPDH) (A) and ± s.d. (E–F). The results are from two independent experiments with a minimum of two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 8 The intracellular localization of β-catenin, the major WNT signaling pathway mediator, is regulated by primary cilia. A-B The active (non-phosphorylated) form of β-catenin is significantly upregulated in an RFX2 -/- background as compared to WT neurons. This upregulation is particularly strong on d2 and d3 of neuron differentiation, the two time points with the highest percentage of ciliation (cf. Fig. 2A). Quantification of expression values (A) was carried out from western blot analysis (B) relative to the housekeeping protein GAPDH (loading control). C-D Active β-catenin immunocytochemistry staining of WT and RFX2 -/- neurons highlights differences between genotypes in intracellular protein localization: note the more prominent nuclear localization in the RFX2 -/- background and in non-ciliated WT neurons as compared to ciliated WT neurons. Circles define nuclei and dashed lines define the cell body; the ciliary marker is ARL13B (green). E–F Quantification of active β-catenin localization based on the ratio of immunofluorescence intensity between the cytoplasm and the nucleus on d1, d2 and d3 of LUHMES neuron differentiation. In WT, ciliated neurons (n = 39–167) more strongly promote β-catenin degradation in the cytoplasm, resulting in diminished translocation to the nucleus of the active form (lower ratio), as compared to non-ciliated neurons (n = 44–95) (higher ratio) (E). In an RFX2 -/- background, ciliated (n = 16–77) and non-ciliated neurons (n = 28–57) show no differences in regulating β-catenin intracellular localization (equal ratios) (F). Mean values are shown ± s.e.m. (normalized to GAPDH) (A) and ± s.d. (E–F). The results are from two independent experiments with a minimum of two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central
Fig. 9 The ciliary WNT signaling pathway regulates the expression of cyto-architectural remodeling genes during neuron differentiation. qRT-PCR analysis of the expression of WNT signaling pathway output genes following pathway inhibition (antagonist Wnt-C59) or activation (agonist Wnt-3a) reveals clear gene expression differences in LUHMES WT neurons as compared to RFX2 -/- neurons with an altered primary cilium. A WT neurons treated with Wnt-C59 show strong downregulation of genes implicated in cyto-architectural organization, including the non-canonical WNT signaling pathway output genes CAMK2A and DAAM1: expression levels are very similar to the basal expression levels of untreated RFX2 -/- neurons (vehicle). B Treatment with a WNT activator (Wnt-3a) results in stronger upregulation of canonical output genes in WT neurons as compared to in the RFX2 -/- background. C qRT-PCR analysis of the expression of a set of canonical WNT signaling pathway output genes (Note: PTK7 is also as non-canonical target gene) following pathway inhibition (antagonist Wnt-C59): for this set of output genes WT neurons treated with Wnt-C59 do not show downregulation of gene expression and their expression levels are very similar to the basal expression levels of untreated (vehicle) RFX2 -/- neurons with an altered primary cilium (exceptions: neuron differentiation markers NEUROG1 and PAX6). These results point toward an involvement of the non-canonical WNT signaling pathway in neuron differentiation to promote cytoskeletal rearrangement and remodeling. Mean values are shown ± s.e.m. (normalized to GAPDH; not shown). The results are from a minimum of three independent experiments with two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001
Fig. 9 The ciliary WNT signaling pathway regulates the expression of cyto-architectural remodeling genes during neuron differentiation. qRT-PCR analysis of the expression of WNT signaling pathway output genes following pathway inhibition (antagonist Wnt-C59) or activation (agonist Wnt-3a) reveals clear gene expression differences in LUHMES WT neurons as compared to RFX2 -/- neurons with an altered primary cilium. A WT neurons treated with Wnt-C59 show strong downregulation of genes implicated in cyto-architectural organization, including the non-canonical WNT signaling pathway output genes CAMK2A and DAAM1: expression levels are very similar to the basal expression levels of untreated RFX2 -/- neurons (vehicle). B Treatment with a WNT activator (Wnt-3a) results in stronger upregulation of canonical output genes in WT neurons as compared to in the RFX2 -/- background. C qRT-PCR analysis of the expression of a set of canonical WNT signaling pathway output genes (Note: PTK7 is also as non-canonical target gene) following pathway inhibition (antagonist Wnt-C59): for this set of output genes WT neurons treated with Wnt-C59 do not show downregulation of gene expression and their expression levels are very similar to the basal expression levels of untreated (vehicle) RFX2 -/- neurons with an altered primary cilium (exceptions: neuron differentiation markers NEUROG1 and PAX6). These results point toward an involvement of the non-canonical WNT signaling pathway in neuron differentiation to promote cytoskeletal rearrangement and remodeling. Mean values are shown ± s.e.m. (normalized to GAPDH; not shown). The results are from a minimum of three independent experiments with two technical replicates each. We conducted regular two-way ANOVA analyses (not repeated measures) with multiple comparisons (Bonferroni’s test) between groups. *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.0001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Cited by

See all 27

Metadata

Authors
Coschiera, A., Yoshihara, M., Lauter, G., Ezer, S., Pucci, M., Li, H., Kavšek, A., Riedel, C. G., Kere, J., & Swoboda, P.
Affiliations
  • Karolinska Institutet (SE)
  • Chiba University (JP)
  • Uppsala University (SE)
  • University of Helsinki (FI)
  • University of Teramo (IT)
Corresponding author
  • Coschiera, Andrea
  • Yoshihara, Masahito
  • Kere, Juha
  • Swoboda, Peter
Venue
BMC Biology
Published
2024-02-27
Volume
22
Issue
1
Pages
48-48
ISSN
1741-7007 (ISSN-L)
OpenAlex
W4392200032
Cited by
26
References
109
Citations by year
2026: 10 · 2025: 13 · 2024: 3
FWCI
6.90
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • UniTERAMO Research Catalog (University of Teramo) (submittedVersion)
Funders
  • Karolinska Institutet
  • Japan Society for the Promotion of Science
  • Hjärnfonden
  • Svenska Sällskapet för Medicinsk Forskning
  • Fredrik och Ingrid Thurings Stiftelse
  • Vetenskapsrådet
  • Sigrid Juséliuksen Säätiö
  • Stiftelsen för Strategisk Forskning
  • Torsten Söderbergs Stiftelse
  • Olle Engkvists Stiftelse
  • Åhlén-stiftelsen
  • O. E. och Edla Johanssons Vetenskapliga Stiftelse
  • Cancerfonden
  • Novo Nordisk
  • Karolinska Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Keywords
primary cilia, neuronal differentiation, Wnt signaling, non-canonical Wnt pathway, RFX2, IFT88, IFT172, LUHMES cells, axon growth, neuronal arborization, neurodevelopmental disorders, ciliopathies
MeSH terms
Cell Differentiation, Cilia, Cytoskeletal Proteins, Humans, Neurons, Adaptor Proteins, Signal Transducing, Neural Stem Cells, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary cilia promote the differentiation of human neurons through the WNT signaling pathway. https://app.cochat.ai/papers/10.1186/s12915-024-01845-w
The paper
Coschiera, A., Yoshihara, M., Lauter, G., Ezer, S., Pucci, M., Li, H., Kavšek, A., Riedel, C. G., Kere, J., & Swoboda, P. (2024). Primary cilia promote the differentiation of human neurons through the WNT signaling pathway. BMC Biology. https://doi.org/10.1186/s12915-024-01845-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.